BioCentury
ARTICLE | Company News

Celgene, PharmAria deal

October 22, 2012 7:00 AM UTC

Celgene will provide seed funding to PharmAria, a company founded earlier this year by alumni from now-acquired inflammation company Amira Pharmaceuticals Inc. Celgene will have an option to license certain R&D programs and an option to acquire the newco, which plans to develop small molecules for cancer and fibrotic diseases. Celgene plans to work with PharmAria to secure series A funding. The companies could not be reached for financial details. ...